A Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004)
Status:
NOT_YET_RECRUITING
Trial end date:
2025-12-27
Target enrollment:
Participant gender:
Summary
Researchers have designed a new study medicine called MK-4646 as a new way to treat human immunodeficiency virus (HIV). Rifabutin is a medication used to treat tuberculosis (TB).
Researchers want to learn about MK-4646 when taken at the same time as Rifabutin.
They want to:
Measure a person's blood to find out if the amount of MK-4646 in the blood is the same when MK-4646 is taken alone or with Rifabutin Learn about the safety of MK-4646 when taken alone or with Rifabutin and if people tolerate it